{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T20:52:08Z","timestamp":1794948728467,"version":"4.9.1"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-56644-w","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T09:37:56Z","timestamp":1738575476000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Duchenne muscular dystrophy: recent insights in brain related comorbidities"],"prefix":"10.1038","volume":"16","author":[{"given":"Cyrille","family":"Vaillend","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9038-7506","authenticated-orcid":false,"given":"Yoshitsugu","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Mercuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos","family":"Hendriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantina","family":"Tetorou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3938-1165","authenticated-orcid":false,"given":"Aurelie","family":"Goyenvalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9102-5232","authenticated-orcid":false,"given":"Francesco","family":"Muntoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,3]]},"reference":[{"key":"56644_CR1","doi-asserted-by":"crossref","unstructured":"Crisafulli, S. et al. Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis. Orphanet. J. Rare Dis. 15, 141 (2020).","DOI":"10.1186\/s13023-020-01430-8"},{"key":"56644_CR2","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/S1474-4422(22)00125-9","volume":"21","author":"T Markati","year":"2022","unstructured":"Markati, T. et al. Emerging therapies for Duchenne muscular dystrophy. Lancet Neurol. 21, 814\u2013829 (2022).","journal-title":"Lancet Neurol."},{"key":"56644_CR3","unstructured":"Duchenne, G.-B. (1806-1875). A. du texte. De la paralysie musculaire pseudo-hypertrophique, ou paralysie myo-scl\u00e9rosique \/ par le Dr Duchenne (de Boulogne). (1868)."},{"key":"56644_CR4","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/dmcn.15481","volume":"65","author":"C Pascual-Morena","year":"2023","unstructured":"Pascual-Morena, C. et al. Global prevalence of intellectual developmental disorder in dystrophinopathies: A systematic review and meta-analysis. Dev. Med Child Neurol. 65, 734\u2013744 (2023).","journal-title":"Dev. Med Child Neurol."},{"key":"56644_CR5","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/mus.26803","volume":"61","author":"AJ Darmahkasih","year":"2020","unstructured":"Darmahkasih, A. J. et al. Neurodevelopmental, behavioral, and emotional symptoms common in Duchenne muscular dystrophy. Muscle Nerve 61, 466\u2013474 (2020).","journal-title":"Muscle Nerve"},{"key":"56644_CR6","doi-asserted-by":"crossref","unstructured":"Hendriksen, J. G. M. & Vles, J. S. H. Neuropsychiatric Disorders in Males With Duchenne Muscular Dystrophy: Frequency Rate of Attention-Deficit Hyperactivity Disorder (ADHD), Autism Spectrum Disorder, and Obsessive\u2014Compulsive Disorder. 10.1177\/0883073807309775 23, 477\u2013481 (2008).","DOI":"10.1177\/0883073807309775"},{"key":"56644_CR7","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S1474-4422(03)00585-4","volume":"2","author":"F Muntoni","year":"2003","unstructured":"Muntoni, F., Torelli, S. & Ferlini, A. Dystrophin and mutations: One gene, several proteins, multiple phenotypes. Lancet Neurol. 2, 731\u2013740 (2003).","journal-title":"Lancet Neurol."},{"key":"56644_CR8","doi-asserted-by":"crossref","unstructured":"Doorenweerd, N. et al. Timing and localization of human dystrophin isoform expression provide insights into the cognitive phenotype of Duchenne muscular dystrophy. Sci. Rep. 7, 12575(2017).","DOI":"10.1038\/s41598-017-12981-5"},{"key":"56644_CR9","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1474-4422(18)30024-3","volume":"17","author":"DJ Birnkrant","year":"2018","unstructured":"Birnkrant, D. J. et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol. 17, 251 (2018).","journal-title":"Lancet Neurol."},{"key":"56644_CR10","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/hmg\/ddac236","volume":"32","author":"C Garc\u00eda-Cruz","year":"2023","unstructured":"Garc\u00eda-Cruz, C. et al. Tissue-and cell-specific whole-transcriptome meta-analysis from brain and retina reveals differential expression of dystrophin complexes and new dystrophin spliced isoforms. Hum. Mol. Genet 32, 659\u2013676 (2023).","journal-title":"Hum. Mol. Genet"},{"key":"56644_CR11","doi-asserted-by":"crossref","unstructured":"Hildyard, J. C. W. et al. Single-transcript multiplex in situ hybridisation reveals unique patterns of dystrophin isoform expression in the developing mammalian embryo. Wellcome Open Res 5, 32724863 (2020).","DOI":"10.12688\/wellcomeopenres.15762.2"},{"key":"56644_CR12","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.bbrc.2022.09.035","volume":"630","author":"A S\u00e1nchez","year":"2022","unstructured":"S\u00e1nchez, A., Arag\u00f3n, J., Ceja, V., Rendon, A. & Montanez, C. Nuclear transport and subcellular localization of the dystrophin Dp71 and Dp40 isoforms in the PC12 cell line. Biochem Biophys. Res Commun. 630, 125\u2013132 (2022).","journal-title":"Biochem Biophys. Res Commun."},{"key":"56644_CR13","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1042\/bj2720557","volume":"272","author":"S Bar","year":"1990","unstructured":"Bar, S. et al. A novel product of the Duchenne muscular dystrophy gene which greatly differs from the known isoforms in its structure and tissue distribution. Biochem. J. 272, 557\u2013560 (1990).","journal-title":"Biochem. J."},{"key":"56644_CR14","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1093\/hmg\/5.10.1559","volume":"5","author":"CN Tennyson","year":"1996","unstructured":"Tennyson, C. N., Dally, G. Y., Ray, P. N. & Worton, R. G. Expression of the dystrophin isoform Dp71 in differentiating human fetal myogenic cultures. Hum. Mol. Genet 5, 1559\u20131566 (1996).","journal-title":"Hum. Mol. Genet"},{"key":"56644_CR15","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1006\/dbio.1996.8430","volume":"181","author":"M Durbeej","year":"1997","unstructured":"Durbeej, M., Jung, D., Hjalt, T., Campbell, K. P. & Ekblom, P. Transient expression of Dp140, a product of the Duchenne muscular dystrophy locus, during kidney tubulogenesis. Dev. Biol. 181, 156\u2013167 (1997).","journal-title":"Dev. Biol."},{"key":"56644_CR16","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/BF02265272","volume":"97","author":"E Holder -Masato Maeda","year":"1996","unstructured":"Holder -Masato Maeda, E. & Bies, R. D. Expression and regulation of the dystrophin Purkinje promoter in human skeletal muscle, heart, and brain. Hum. Genet 97, 232\u2013239 (1996).","journal-title":"Hum. Genet"},{"key":"56644_CR17","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/mus.25383","volume":"55","author":"Y Suzuki","year":"2017","unstructured":"Suzuki, Y., Higuchi, S., Aida, I., Nakajima, T. & Nakada, T. Abnormal distribution of GABAA receptors in brain of duchenne muscular dystrophy patients. Muscle Nerve 55, 591\u2013595 (2017).","journal-title":"Muscle Nerve"},{"key":"56644_CR18","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.1046\/j.1460-9568.1999.00887.x","volume":"11","author":"I Knuesel","year":"1999","unstructured":"Knuesel, I. et al. Short communication: altered synaptic clustering of GABAA receptors in mice lacking dystrophin (mdx mice). Eur. J. Neurosci. 11, 4457\u20134462 (1999).","journal-title":"Eur. J. Neurosci."},{"key":"56644_CR19","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/brain\/awn253","volume":"132","author":"M Sekiguchi","year":"2009","unstructured":"Sekiguchi, M. et al. A deficit of brain dystrophin impairs specific amygdala GABAergic transmission and enhances defensive behaviour in mice. Brain 132, 124\u2013135 (2009).","journal-title":"Brain"},{"key":"56644_CR20","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.neuint.2018.06.001","volume":"118","author":"JD Pereira da Silva","year":"2018","unstructured":"Pereira da Silva, J. D. et al. Altered release and uptake of gamma-aminobutyric acid in the cerebellum of dystrophin-deficient mice. Neurochem. Int. 118, 105\u2013114 (2018).","journal-title":"Neurochem. Int"},{"key":"56644_CR21","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/hipo.10068","volume":"12","author":"C Vaillend","year":"2002","unstructured":"Vaillend, C. & Billard, J. M. Facilitated CA1 hippocampal synaptic plasticity in dystrophin-deficient mice: Role for GABAA receptors? Hippocampus 12, 713\u2013717 (2002).","journal-title":"Hippocampus"},{"key":"56644_CR22","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1523\/JNEUROSCI.1256-21.2022","volume":"42","author":"WC Wu","year":"2022","unstructured":"Wu, W. C., Bradley, S. P., Christie, J. M. & Pugh, J. R. Mechanisms and consequences of cerebellar purkinje cell disinhibition in a mouse model of duchenne muscular dystrophy. J. Neurosci. 42, 2103\u20132115 (2022).","journal-title":"J. Neurosci."},{"key":"56644_CR23","doi-asserted-by":"publisher","first-page":"926518","DOI":"10.3389\/fncel.2022.926518","volume":"16","author":"T Kreko-Pierce","year":"2022","unstructured":"Kreko-Pierce, T. & Pugh, J. R. Altered synaptic transmission and excitability of cerebellar nuclear neurons in a mouse model of duchenne muscular dystrophy. Front Cell Neurosci. 16, 926518 (2022).","journal-title":"Front Cell Neurosci."},{"key":"56644_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/ijms232012617","volume":"23","author":"F Zarrouki","year":"2022","unstructured":"Zarrouki, F. et al. Abnormal expression of synaptic and extrasynaptic gabaa receptor subunits in the dystrophin-deficient mdx mouse. Int J. Mol. Sci. 23, 23 (2022).","journal-title":"Int J. Mol. Sci."},{"key":"56644_CR25","first-page":"1041","volume":"26","author":"C Vaillend","year":"2017","unstructured":"Vaillend, C. & Chaussenot, R. Relationships linking emotional, motor, cognitive and GABAergic dysfunctions in dystrophin-deficient mdx mice. Hum. Mol. Genet 26, 1041\u20131055 (2017).","journal-title":"Hum. Mol. Genet"},{"key":"56644_CR26","doi-asserted-by":"publisher","first-page":"103482","DOI":"10.1016\/j.mcn.2020.103482","volume":"104","author":"R Bianchi","year":"2020","unstructured":"Bianchi, R. et al. Hippocampal synaptic and membrane function in the DBA\/2J-mdx mouse model of Duchenne muscular dystrophy. Mol. Cell. Neurosci. 104, 103482 (2020).","journal-title":"Mol. Cell. Neurosci."},{"key":"56644_CR27","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1006\/bbrc.1997.7328","volume":"238","author":"E Araki","year":"1997","unstructured":"Araki, E. et al. Targeted Disruption of Exon 52 in the Mouse Dystrophin Gene Induced Muscle Degeneration Similar to That Observed in Duchenne Muscular Dystrophy. Biochem Biophys. Res Commun. 238, 492\u2013497 (1997).","journal-title":"Biochem Biophys. Res Commun."},{"key":"56644_CR28","doi-asserted-by":"crossref","unstructured":"Hashimoto, Y. et al. Brain Dp140 alters glutamatergic transmission and social behaviour in the mdx52 mouse model of Duchenne muscular dystrophy. Prog. Neurobiol. 216, 10.1016\/j.pneurobio.2022.102288 (2022).","DOI":"10.1016\/j.pneurobio.2022.102288"},{"key":"56644_CR29","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s00424-023-02803-1","volume":"475","author":"M Leyva-Leyva","year":"2023","unstructured":"Leyva-Leyva, M. et al. Identification of Dp140 and \u03b11-syntrophin as novel molecular interactors of the neuronal CaV2.1 channel. Pflug. Arch. 475, 595\u2013606 (2023).","journal-title":"Pflug. Arch."},{"key":"56644_CR30","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1002\/glia.23941","volume":"69","author":"M Belmaati Cherkaoui","year":"2021","unstructured":"Belmaati Cherkaoui, M. et al. Dp71 contribution to the molecular scaffold anchoring aquaporine-4 channels in brain macroglial cells. Glia 69, 954\u2013970 (2021).","journal-title":"Glia"},{"key":"56644_CR31","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/glia.24116","volume":"70","author":"J Lange","year":"2022","unstructured":"Lange, J. et al. Dystrophin deficiency affects human astrocyte properties and response to damage. Glia 70, 466\u2013490 (2022).","journal-title":"Glia"},{"key":"56644_CR32","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3233\/JND-221586","volume":"10","author":"C Pascual-Morena","year":"2023","unstructured":"Pascual-Morena, C. et al. Dystrophin genotype and risk of neuropsychiatric disorders in dystrophinopathies: a systematic review and meta-analysis. J. Neuromuscul. Dis. 10, 159 (2023).","journal-title":"J. Neuromuscul. Dis."},{"key":"56644_CR33","doi-asserted-by":"crossref","unstructured":"Weerkamp, P. M. M. et al. Wechsler scale intelligence testing in males with dystrophinopathies: a review and meta-analysis. Brain Sci 12, 10.3390\/brainsci12111544 (2022).","DOI":"10.3390\/brainsci12111544"},{"key":"56644_CR34","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/S0960-8966(01)00274-7","volume":"12","author":"A von Gontard","year":"2002","unstructured":"von Gontard, A. et al. Intelligence and cognitive function in children and adolescents with spinal muscular atrophy. Neuromuscul. Disord. 12, 130\u2013136 (2002).","journal-title":"Neuromuscul. Disord."},{"key":"56644_CR35","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/jcm10204777","volume":"10","author":"R D\u2019alessandro","year":"2021","unstructured":"D\u2019alessandro, R. et al. Assessing cognitive function in neuromuscular diseases: A pilot study in a sample of children and adolescents. J. Clin. Med 10, 10 (2021).","journal-title":"J. Clin. Med"},{"key":"56644_CR36","doi-asserted-by":"publisher","first-page":"e541","DOI":"10.1097\/DBP.0000000000001105","volume":"43","author":"I Lee","year":"2022","unstructured":"Lee, I. et al. The hidden disease: delayed diagnosis in duchenne muscular dystrophy and co-occurring conditions. J. Dev. Behav. Pediatr. 43, e541\u2013e545 (2022).","journal-title":"J. Dev. Behav. Pediatr."},{"key":"56644_CR37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/jcm12020403","volume":"12","author":"DPR Chieffo","year":"2023","unstructured":"Chieffo, D. P. R. et al. A longitudinal follow-up study of intellectual function in duchenne muscular dystrophy over age: is it really stable? J. Clin. Med 12, 12 (2023).","journal-title":"J. Clin. Med"},{"key":"56644_CR38","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3233\/JND-210640","volume":"8","author":"G Norcia","year":"2021","unstructured":"Norcia, G. et al. Early gross motor milestones in duchenne muscular dystrophy. J. Neuromuscul. Dis. 8, 453 (2021).","journal-title":"J. Neuromuscul. Dis."},{"key":"56644_CR39","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1002\/jcsm.12914","volume":"13","author":"M Chesshyre","year":"2022","unstructured":"Chesshyre, M. et al. Investigating the role of dystrophin isoform deficiency in motor function in Duchenne muscular dystrophy. J. Cachexia Sarcopenia Muscle 13, 1360 (2022).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"56644_CR40","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.nmd.2019.09.010","volume":"29","author":"G Coratti","year":"2019","unstructured":"Coratti, G. et al. Longitudinal natural history in young boys with Duchenne muscular dystrophy. Neuromuscul. Disord. 29, 857\u2013862 (2019).","journal-title":"Neuromuscul. Disord."},{"key":"56644_CR41","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.nmd.2013.02.012","volume":"23","author":"M Pane","year":"2013","unstructured":"Pane, M. et al. Early neurodevelopmental assessment in Duchenne muscular dystrophy. Neuromuscul. Disord. 23, 451\u2013455 (2013).","journal-title":"Neuromuscul. Disord."},{"key":"56644_CR42","doi-asserted-by":"publisher","first-page":"5637","DOI":"10.3390\/jcm12175637","volume":"12","author":"N Wijekoon","year":"2023","unstructured":"Wijekoon, N. et al. Duchenne muscular dystrophy from brain to muscle: the role of brain dystrophin isoforms in motor functions. J. Clin. Med 12, 5637 (2023).","journal-title":"J. Clin. Med"},{"key":"56644_CR43","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1111\/dmcn.15176","volume":"64","author":"AA Zambon","year":"2022","unstructured":"Zambon, A. A. et al. Peak functional ability and age at loss of ambulation in Duchenne muscular dystrophy. Dev. Med Child Neurol. 64, 979 (2022).","journal-title":"Dev. Med Child Neurol."},{"key":"56644_CR44","doi-asserted-by":"crossref","unstructured":"Coratti, G. et al. Age, corticosteroid treatment and site of mutations affect motor functional changes in young boys with Duchenne Muscular Dystrophy. PLoS One 17, N\/A-N\/A (2022).","DOI":"10.1371\/journal.pone.0271681"},{"key":"56644_CR45","doi-asserted-by":"publisher","first-page":"e12914","DOI":"10.1111\/nan.12914","volume":"49","author":"C Pascual-Morena","year":"2023","unstructured":"Pascual-Morena, C. et al. Intelligence quotient\u2013genotype association in dystrophinopathies: A systematic review and meta-analysis. Neuropathol. Appl Neurobiol. 49, e12914 (2023).","journal-title":"Neuropathol. Appl Neurobiol."},{"key":"56644_CR46","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1017\/S1355617717001333","volume":"24","author":"RJ Fee","year":"2018","unstructured":"Fee, R. J., Montes, J., Stewart, J. L. & Hinton, V. J. Executive Skills and Academic Achievement in the Dystrophinopathies. J. Int. Neuropsychological Soc. 24, 928\u2013938 (2018).","journal-title":"J. Int. Neuropsychological Soc."},{"key":"56644_CR47","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.nmd.2021.01.011","volume":"31","author":"R Battini","year":"2021","unstructured":"Battini, R. et al. Longitudinal data of neuropsychological profile in a cohort of Duchenne muscular dystrophy boys without cognitive impairment. Neuromuscul. Disord. 31, 319\u2013327 (2021).","journal-title":"Neuromuscul. Disord."},{"key":"56644_CR48","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1469-8749.1998.tb15351.x","volume":"40","author":"C Billard","year":"1998","unstructured":"Billard, C., Gillet, P., Barthez, M. A., Hommet, C. & Bertrand, P. Reading ability and processing in Duchenne muscular dystrophy and spinal muscular atrophy. Dev. Med Child Neurol. 40, 12\u201320 (1998).","journal-title":"Dev. Med Child Neurol."},{"key":"56644_CR49","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.pediatrneurol.2005.08.029","volume":"34","author":"JGM Hendriksen","year":"2006","unstructured":"Hendriksen, J. G. M. & Vles, J. S. H. Are Males With Duchenne Muscular Dystrophy at Risk for Reading Disabilities? Pediatr. Neurol. 34, 296\u2013300 (2006).","journal-title":"Pediatr. Neurol."},{"key":"56644_CR50","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ridd.2015.07.025","volume":"45\u201346","author":"G Astrea","year":"2015","unstructured":"Astrea, G. et al. Reading impairment in Duchenne muscular dystrophy: A pilot study to investigate similarities and differences with developmental dyslexia. Res Dev. Disabil. 45\u201346, 168\u2013177 (2015).","journal-title":"Res Dev. Disabil."},{"key":"56644_CR51","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.neuroscience.2015.08.034","volume":"309","author":"R Schmidt-Kastner","year":"2015","unstructured":"Schmidt-Kastner, R. Genomic approach to selective vulnerability of the hippocampus in brain ischemia-hypoxia. Neuroscience 309, 259\u2013279 (2015).","journal-title":"Neuroscience"},{"key":"56644_CR52","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/dmcn.12922","volume":"58","author":"V Ricotti","year":"2016","unstructured":"Ricotti, V. et al. Neurodevelopmental, emotional, and behavioural problems in Duchenne muscular dystrophy in relation to underlying dystrophin gene mutations. Dev. Med Child Neurol. 58, 77\u201384 (2016).","journal-title":"Dev. Med Child Neurol."},{"key":"56644_CR53","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.jpeds.2012.03.020","volume":"161","author":"M Pane","year":"2012","unstructured":"Pane, M. et al. Attention deficit hyperactivity disorder and cognitive function in duchenne muscular dystrophy: Phenotype-genotype correlation. J. Pediatrics 161, 705\u2013709.e1 (2012).","journal-title":"J. Pediatrics"},{"key":"56644_CR54","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1016\/j.apmr.2022.05.015","volume":"103","author":"C Pascual-Morena","year":"2022","unstructured":"Pascual-Morena, C. et al. Prevalence of Neuropsychiatric Disorders in Duchenne and Becker Muscular Dystrophies: A Systematic Review and Meta-analysis. Arch. Phys. Med Rehabil. 103, 2444\u20132453 (2022).","journal-title":"Arch. Phys. Med Rehabil."},{"key":"56644_CR55","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.nmd.2023.12.002","volume":"34","author":"RE Trimmer","year":"2024","unstructured":"Trimmer, R. E., Mandy, W. P. L., Muntoni, F. & Maresh, K. E. Understanding anxiety experienced by young males with Duchenne muscular dystrophy: a qualitative focus group study. Neuromuscul. Disord. 34, 95\u2013104 (2024).","journal-title":"Neuromuscul. Disord."},{"key":"56644_CR56","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/brain\/awac048","volume":"146","author":"K Maresh","year":"2023","unstructured":"Maresh, K. et al. Startle responses in Duchenne muscular dystrophy: a novel biomarker of brain dystrophin deficiency. Brain 146, 252\u2013265 (2023).","journal-title":"Brain"},{"key":"56644_CR57","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.nmd.2020.08.357","volume":"30","author":"JGM Hendriksen","year":"2020","unstructured":"Hendriksen, J. G. M. et al. 249th ENMC International Workshop: The role of brain dystrophin in muscular dystrophy: Implications for clinical care and translational research, Hoofddorp, The Netherlands, November 29th\u2013December 1st 2019. Neuromuscul. Disord. 30, 782\u2013794 (2020).","journal-title":"Neuromuscul. Disord."},{"key":"56644_CR58","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/ana.24222","volume":"76","author":"N Doorenweerd","year":"2014","unstructured":"Doorenweerd, N. et al. Reduced cerebral gray matter and altered white matter in boys with Duchenne muscular dystrophy. Ann. Neurol. 76, 403\u2013411 (2014).","journal-title":"Ann. Neurol."},{"key":"56644_CR59","doi-asserted-by":"publisher","first-page":"6785","DOI":"10.1093\/cercor\/bhac542","volume":"33","author":"B Cheng","year":"2023","unstructured":"Cheng, B. et al. Connectomic disturbances in Duchenne muscular dystrophy with mild cognitive impairment. Cereb. Cortex 33, 6785\u20136791 (2023).","journal-title":"Cereb. Cortex"},{"key":"56644_CR60","doi-asserted-by":"crossref","unstructured":"Biagi, L. et al. Neural substrates of neuropsychological profiles in dystrophynopathies: A pilot study of diffusion tractography imaging. PLoS One 16, 10.1371\/journal.pone.0250420 (2021).","DOI":"10.1371\/journal.pone.0250420"},{"key":"56644_CR61","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1007\/s11682-020-00422-3","volume":"15","author":"N Doorenweerd","year":"2021","unstructured":"Doorenweerd, N. et al. Resting-state functional MRI shows altered default-mode network functional connectivity in Duchenne muscular dystrophy patients. Brain Imaging Behav. 15, 2297 (2021).","journal-title":"Brain Imaging Behav."},{"key":"56644_CR62","doi-asserted-by":"publisher","unstructured":"Preethish-Kumar, V. et al. In Vivo Evaluation of White Matter Abnormalities in Children with Duchenne Muscular Dystrophy Using DTI. https:\/\/doi.org\/10.3174\/ajnr.A6604.","DOI":"10.3174\/ajnr.A6604"},{"key":"56644_CR63","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/mus.27057","volume":"62","author":"H Demirci","year":"2020","unstructured":"Demirci, H. et al. Cognition of the mothers of patients with Duchenne muscular dystrophy. Muscle Nerve 62, 710\u2013716 (2020).","journal-title":"Muscle Nerve"},{"key":"56644_CR64","doi-asserted-by":"publisher","first-page":"3511","DOI":"10.1017\/S0033291722000083","volume":"53","author":"M Rose","year":"2023","unstructured":"Rose, M. et al. A randomised controlled trial of acceptance and commitment therapy for improving quality of life in people with muscle diseases. Psychol. Med 53, 3511 (2023).","journal-title":"Psychol. Med"},{"key":"56644_CR65","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/j.euroneuro.2019.10.011","volume":"29","author":"RAH Adan","year":"2019","unstructured":"Adan, R. A. H. et al. Nutritional psychiatry: Towards improving mental health by what you eat. Eur. Neuropsychopharmacol. 29, 1321\u20131332 (2019).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"56644_CR66","doi-asserted-by":"crossref","unstructured":"Wolf, T. G., Faerber, K. A., Rummel, C., Halsband, U. & Campus, G. Functional changes in brain activity using hypnosis: a systematic review. Brain Sci 12, 10.3390\/brainsci12010108 (2022).","DOI":"10.3390\/brainsci12010108"},{"key":"56644_CR67","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1080\/09602011.2022.2096080","volume":"33","author":"DMJ Hellebrekers","year":"2023","unstructured":"Hellebrekers, D. M. J. et al. Computerized working memory training in males with Duchenne muscular dystrophy: A single case experimental design study. Neuropsychol. Rehabil. 33, 1325\u20131348 (2023).","journal-title":"Neuropsychol. Rehabil."},{"key":"56644_CR68","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S2215-0366(23)00345-0","volume":"11","author":"S Cortese","year":"2024","unstructured":"Cortese, S. et al. Psychopharmacology in children and adolescents: unmet needs and opportunities. Lancet Psychiatry 11, 143\u2013154 (2024).","journal-title":"Lancet Psychiatry"},{"key":"56644_CR69","doi-asserted-by":"crossref","unstructured":"Brusa, C. et al. Psychopharmacological treatments for mental disorders in patients with neuromuscular diseases: a scoping review. Brain Sci. 12, 10.3390\/brainsci12020176 (2022).","DOI":"10.3390\/brainsci12020176"},{"key":"56644_CR70","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ejpn.2018.09.005","volume":"23","author":"JM Lionarons","year":"2019","unstructured":"Lionarons, J. M. et al. Methylphenidate use in males with Duchenne muscular dystrophy and a comorbid attention-deficit hyperactivity disorder. Eur. J. Paediatr. Neurol. 23, 152\u2013157 (2019).","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"56644_CR71","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1177\/0883073818774439","volume":"33","author":"AJ Lee","year":"2018","unstructured":"Lee, A. J., Buckingham, E. T., Kauer, A. J. & Mathews, K. D. Descriptive phenotype of obsessive compulsive symptoms in males with Duchenne Muscular Dystrophy. J. Child Neurol. 33, 572 (2018).","journal-title":"J. Child Neurol."},{"key":"56644_CR72","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.nmd.2023.05.011","volume":"33","author":"PMM Weerkamp","year":"2023","unstructured":"Weerkamp, P. M. M. et al. Psychopharmaceutical treatment for neurobehavioral problems in Duchenne muscular dystrophy: a descriptive study using real-world data. Neuromuscul. Disord. 33, 619\u2013626 (2023).","journal-title":"Neuromuscul. Disord."},{"key":"56644_CR73","doi-asserted-by":"crossref","unstructured":"Gadaleta, G. et al. Adults living with Duchenne muscular dystrophy: old and new challenges in a cohort of 19 patients in their third to fifth decade. Eur. J. Neurol. 31, e16060 (2024).","DOI":"10.1111\/ene.16060"},{"key":"56644_CR74","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.nmd.2023.12.003","volume":"35","author":"L Nart","year":"2024","unstructured":"Nart, L., Desikan, M., Pietrusz, A., Savvatis, K. & Quinlivan, R. Neurodiversity, treatment compliance and survival in adults with Duchenne muscular dystrophy: a single-centre retrospective cohort review. Neuromuscul. Disord. 35, 13\u201318 (2024).","journal-title":"Neuromuscul. Disord."},{"key":"56644_CR75","doi-asserted-by":"publisher","first-page":"e119243","DOI":"10.3897\/rio.10.e119243","volume":"10","author":"L Bouquillon","year":"2024","unstructured":"Bouquillon, L. et al. Workshop report: Workshop on psychiatric prescribing and psychology testing and intervention in children and adults with Duchenne muscular dystrophy. Res. Ideas Outcomes 10 10, e119243 (2024).","journal-title":"Res. Ideas Outcomes 10"},{"key":"56644_CR76","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1017\/S0033291716002774","volume":"47","author":"K Kamenov","year":"2017","unstructured":"Kamenov, K., Twomey, C., Cabello, M., Prina, A. M. & Ayuso-Mateos, J. L. The efficacy of psychotherapy, pharmacotherapy and their combination on functioning and quality of life in depression: a meta-analysis. Psychol. Med 47, 414\u2013425 (2017).","journal-title":"Psychol. Med"},{"key":"56644_CR77","doi-asserted-by":"crossref","unstructured":"DeRubeis, R. J., Siegle, G. J. & Hollon, S. D. Cognitive therapy versus medication for depression: treatment outcomes and neural mechanisms. Nat. Rev. Neurosci. 9, 788\u2013796 (2008).","DOI":"10.1038\/nrn2345"},{"key":"56644_CR78","doi-asserted-by":"publisher","unstructured":"Van Putten, M. et al. Mouse models for muscular dystrophies: an overview. https:\/\/doi.org\/10.1242\/dmm.043562 (2020).","DOI":"10.1242\/dmm.043562"},{"key":"56644_CR79","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.nbd.2004.05.004","volume":"17","author":"C Vaillend","year":"2004","unstructured":"Vaillend, C., Billard, J. M. & Laroche, S. Impaired long-term spatial and recognition memory and enhanced CA1 hippocampal LTP in the dystrophin-deficient Dmdmdx mouse. Neurobiol. Dis. 17, 10\u201320 (2004).","journal-title":"Neurobiol. Dis."},{"key":"56644_CR80","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1113\/EP091274","volume":"108","author":"CA Bellissimo","year":"2023","unstructured":"Bellissimo, C. A. et al. Memory impairment in the D2.mdx mouse model of Duchenne muscular dystrophy is prevented by the adiponectin receptor agonist ALY688. Exp. Physiol. 108, 1108\u20131117 (2023).","journal-title":"Exp. Physiol."},{"key":"56644_CR81","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1037\/0735-7044.106.2.274","volume":"106","author":"RG Phillips","year":"1992","unstructured":"Phillips, R. G. & LeDoux, J. E. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav. Neurosci. 106, 274\u2013285 (1992).","journal-title":"Behav. Neurosci."},{"key":"56644_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2164-13-233","volume":"13","author":"DJ Nonneman","year":"2012","unstructured":"Nonneman, D. J., Brown-Brandl, T., Jones, S. A., Wiedmann, R. T. & Rohrer, G. A. A defect in dystrophin causes a novel porcine stress syndrome. BMC Genomics 13, 1\u20139 (2012).","journal-title":"BMC Genomics"},{"key":"56644_CR83","doi-asserted-by":"crossref","unstructured":"Caudal, D. et al. Characterization of brain dystrophins absence and impact in dystrophin-deficient Dmdmdx rat model. PLoS One 15, e0230083 (2020).","DOI":"10.1371\/journal.pone.0230083"},{"key":"56644_CR84","doi-asserted-by":"publisher","first-page":"102700","DOI":"10.1016\/j.ebiom.2020.102700","volume":"55","author":"M Razzoli","year":"2020","unstructured":"Razzoli, M. et al. Social stress is lethal in the mdx model of Duchenne muscular dystrophy. EBioMedicine 55, 102700 (2020).","journal-title":"EBioMedicine"},{"key":"56644_CR85","doi-asserted-by":"crossref","unstructured":"Saoudi, A. et al. Emotional behavior and brain anatomy of the mdx52 mouse model of Duchenne muscular dystrophy. Dis. Model Mech. 14, dmm049028 (2021).","DOI":"10.1242\/dmm.049028"},{"key":"56644_CR86","doi-asserted-by":"crossref","unstructured":"Verhaeg, M. et al. Learning, memory and blood\u2013brain barrier pathology in Duchenne muscular dystrophy mice lacking Dp427, or Dp427 and Dp140. Genes Brain Behav. 23, 10.1111\/gbb.12895 (2024).","DOI":"10.1111\/gbb.12895"},{"key":"56644_CR87","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0306-4522(98)00023-2","volume":"86","author":"C Vaillend","year":"1998","unstructured":"Vaillend, C. et al. Spatial discrimination learning and CA1 hippocampal synaptic plasticity in mdx and mdx3cv mice lacking dystrophin gene products. Neuroscience 86, 53\u201366 (1998).","journal-title":"Neuroscience"},{"key":"56644_CR88","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/S0960-8966(99)00029-2","volume":"9","author":"C Vaillend","year":"1999","unstructured":"Vaillend, C. & Ungerer, A. Behavioral characterization of mdx3cv mice deficient in C-terminal dystrophins. Neuromuscul. Disord. 9, 296\u2013304 (1999).","journal-title":"Neuromuscul. Disord."},{"key":"56644_CR89","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1007\/s12035-018-1259-6","volume":"56","author":"R Chaussenot","year":"2019","unstructured":"Chaussenot, R., Amar, M., Fossier, P. & Vaillend, C. Dp71-dystrophin deficiency alters prefrontal cortex excitation-inhibition balance and executive functions. Mol. Neurobiol. 56, 2670\u20132684 (2019).","journal-title":"Mol. Neurobiol."},{"key":"56644_CR90","doi-asserted-by":"crossref","unstructured":"Miranda, R. et al. Social and emotional alterations in mice lacking the short dystrophin-gene product, Dp71. Behav. Brain Funct. 20, 10.1186\/s12993-024-00246-x (2024).","DOI":"10.1186\/s12993-024-00246-x"},{"key":"56644_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12868-023-00788-2","volume":"24","author":"AH Crawford","year":"2023","unstructured":"Crawford, A. H., Hornby, N. L., de la Fuente, A. G. & Piercy, R. J. Brain magnetic resonance imaging in the DE50-MD dog model of Duchenne muscular dystrophy reveals regional reductions in cerebral gray matter. BMC Neurosci. 24, 1\u20139 (2023).","journal-title":"BMC Neurosci."},{"key":"56644_CR92","doi-asserted-by":"crossref","unstructured":"Crawford, A. H. et al. Validation of DE50-MD dogs as a model for the brain phenotype of Duchenne muscular dystrophy. DMM Dis. Model. Mech. 15, dmm049291 (2022).","DOI":"10.1242\/dmm.049291"},{"key":"56644_CR93","doi-asserted-by":"crossref","unstructured":"Stirm, M. et al. A scalable, clinically severe pig model for Duchenne muscular dystrophy. DMM Dis. Model. Mech. 14, dmm049285 (2021).","DOI":"10.1242\/dmm.049285"},{"key":"56644_CR94","first-page":"270","volume":"21","author":"A Goyenvalle","year":"2015","unstructured":"Goyenvalle, A. et al. Functional correction in mouse models of muscular dystrophy using exon-skipping tricyclo-DNA oligomers. Nat. Med. 2015 21:3 21, 270\u2013275 (2015).","journal-title":"Nat. Med. 2015 21:3"},{"key":"56644_CR95","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.nbd.2011.05.012","volume":"43","author":"G Dall\u00e9rac","year":"2011","unstructured":"Dall\u00e9rac, G. et al. Rescue of a dystrophin-like protein by exon skipping normalizes synaptic plasticity in the hippocampus of the mdx mouse. Neurobiol. Dis. 43, 635\u2013641 (2011).","journal-title":"Neurobiol. Dis."},{"key":"56644_CR96","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.omtn.2023.03.009","volume":"32","author":"A Saoudi","year":"2023","unstructured":"Saoudi, A. et al. Partial restoration of brain dystrophin by tricyclo-DNA antisense oligonucleotides alleviates emotional deficits in mdx52 mice. Mol. Ther. Nucleic Acids 32, 173\u2013188 (2023).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"56644_CR97","doi-asserted-by":"crossref","unstructured":"Helleringer, R. et al. Cerebellar synapse properties and cerebellum-dependent motor and non-motor performance in Dp71-null mice. DMM Disease Models and Mechanisms 11, 10.1242\/dmm.033258 (2018).","DOI":"10.1242\/dmm.033258"},{"key":"56644_CR98","doi-asserted-by":"crossref","unstructured":"Miranda, R. et al. Altered social behavior and ultrasonic communication in the dystrophin-deficient mdx mouse model of Duchenne muscular dystrophy. Mol. Autism 6, 10.1186\/s13229-015-0053-9 (2015).","DOI":"10.1186\/s13229-015-0053-9"},{"key":"56644_CR99","doi-asserted-by":"crossref","unstructured":"Daoud, F. et al. Role of mental retardation-associated dystrophin-gene product dp71 in excitatory synapse organization, synaptic plasticity and behavioral functions. PLoS One 4, e6574 (2009).","DOI":"10.1371\/journal.pone.0006574"},{"key":"56644_CR100","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.nlm.2015.07.006","volume":"124","author":"R Chaussenot","year":"2015","unstructured":"Chaussenot, R. et al. Cognitive dysfunction in the dystrophin-deficient mouse model of Duchenne muscular dystrophy: A reappraisal from sensory to executive processes. Neurobiol. Learn Mem. 124, 111\u2013122 (2015).","journal-title":"Neurobiol. Learn Mem."},{"key":"56644_CR101","unstructured":"Tetorou, K. Created in BioRender. https:\/\/BioRender.com\/u06g263 (2024)."},{"key":"56644_CR102","doi-asserted-by":"crossref","unstructured":"Michael, N. & Karen, A. Dystrophin Dp71 and the Neuropathophysiology of Duchenne Muscular Dystrophy. Mol Neurobiol. 57, 1748\u20131767 (2020).","DOI":"10.1007\/s12035-019-01845-w"},{"key":"56644_CR103","unstructured":"Tetorou, K. Created in BioRender. https:\/\/BioRender.com\/w86l794 (2024)."},{"key":"56644_CR104","unstructured":"Tetorou, K. Created in BioRender. https:\/\/BioRender.com\/y58j574 (2024)."},{"key":"56644_CR105","unstructured":"Tetorou, K. Created in BioRender. https:\/\/BioRender.com\/q88i529 (2024)."},{"key":"56644_CR106","unstructured":"Tetorou, K. Created in BioRender. https:\/\/BioRender.com\/b76v061 (2024)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56644-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56644-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56644-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:04:09Z","timestamp":1791857049000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56644-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,3]]},"references-count":106,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["56644"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-56644-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,3]]},"assertion":[{"value":"27 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the version of the article initially published, the peer review statement incorrectly said that a peer review file was available. The peer review statement has now been corrected in the HTML and PDF versions of the article.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests. F.M. has received grants, speaker, and consultancy honoraria from Sarepta Therapeutics, Roche, PTC Therapeutics, Dyne Therapeutics, and Pfizer. E.M. has received grants, speaker, and consultancy honoraria from Sarepta Therapeutics, Roche, Italfarmaco. Y.A. has received grants and consultancy honoraria from Nippon Shinyaku Co., Ltd. and grants from Shionogi & Co., Ltd. C.V., J.H., K.T. and A.G., declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"1298"}}